|

Omeprazole 80 mg twice daily Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Wake Forest University Health Sciences1

Indications

  • Castration-Resistant Prostatic Cancer1
  • Refractory Cancer1
  • Prostate Cancer1
  • Cancer1

Salisbury, North Carolina1 trial

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

W.G. Bill Hefner VA Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.